Showing results (341-350 of 653) with videos related to
Sort By:
Pageof 66
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathwayElvin Blanco, Takafumi Sangai, Suhong Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway TrialFunda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney, et al.British Journal of Cancer|February 21, 2018
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trialsShiraj Sen, Kenneth Hess, David S Hong, et al.Cancer|January 28, 2004
Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinomaTimothy M Pawlik, Allison Perry, Eric A Strom, et al.Journal of the American College of Surgeons|April 5, 2005
Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situTina W F Yen, Kelly K Hunt, Merrick I Ross, et al.NPJ Breast Cancer|December 20, 2025
Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profilingGeorge W Sledge, Joanne Xiu, Reshma L Mahtani, et al.Oncotarget|September 28, 2014
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitorsBurhan Hassan, Argun Akcakanat, Takafumi Sangai, et al.Oncotarget|April 22, 2017
Antiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancerZhijie Wang, Sarina Piha-Paul, Filip Janku, et al.Annals of Surgery|January 8, 2013
Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapyElizabeth A Mittendorf, Thomas A Buchholz, Susan L Tucker, et al.Molecular Cancer Therapeutics|September 26, 2014
Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agentsPrasanth Ganesan, Stacy Moulder, J Jack Lee, et al.Pageof 66